A national survey of 1,154 ob/gyns with a variety of religious affiliations found general support for the use of contraception, though some respondents had ethical reservations about specific contraceptive methods.
A national survey of 1,154 ob/gyns with a variety of religious affiliations found general support for the use of contraception, though some respondents had ethical reservations about specific contraceptive methods. Nonetheless, only a small proportion of surveyed ob/gyns would refuse a woman's request for a specific contraceptive.
Using a written questionnaire, investigators asked respondents if they had a moral or ethical objection to any of 6 common contraceptives and whether they would offer the method if a patient requested it. Respondents also were queried about their views of natural family planning and the importance of religion in their lives.
Overall, 4.9% of respondents had a moral or ethical objection to a contraceptive method, with 1.1% having such an objection to all 6 contraceptives. Yet most physicians who indicated they would not offer 1 or more contraceptives (6.8% of respondents) cited no moral or ethical objectives, suggesting that other concerns contribute to their willingness to provide specific contraceptives, according to the authors. The most common objection was to intrauterine devices, followed by progesterone implants or injections, tubal ligations, oral contraceptive pills, condoms, and the diaphragm or cervical cap with spermicide.
Lawrence RE, Rasinski KA, Yoon JD, Curlin FA. Obstetrician-gynecologists' views on contraception and natural family planning: a national survey. Am J Obstet Gynecol. November 10, 2010. [Epub ahead of print.]
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More